News | February 16, 2011

Ziehm Imaging Receives Frost & Sullivan Award

February 16, 2011 – Ziehm Imaging has received Frost & Sullivan's European Product Leadership Award 2011 in the interventional radiology category.

The Ziehm Vision RFD mobile C-arm ranked strongly in all assessment categories and led the field in terms of functionality, innovation, market acceptance, customer value and quality. The system uses high-resolution, distortion-free flat-panel technology that allows physicians to do procedures that were previously only possible with fixed angiography X-ray systems.

In light of the growing popularity of minimally invasive cardiovascular procedures, the decision from Frost & Sullivan analysts underscores the increasing value of mobile C-arms in hybrid operating rooms. It delivers optimum image quality during complex interventions over an almost unlimited period of time. The C-arm offers the advantage of flexibility, mobility and significantly lowers the investment cost typically required for a fixed system in a hybrid operating room (OR).

The European Product Leadership Award 2011 is the fourth prize Ziehm Imaging received from Frost & Sullivan. The company received awards in several categories in 2006, 2007 and 2009.

For more information: www.ziehm.com

Related Content

Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery| May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery| May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery| May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery| May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery| May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery| February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
Overlay Init